The Lancet Diabetes & Endocrinology , 12(3), 201-213
Longer-term safety questions including effects on the pancreas, thyroid, gallbladder, and cardiovascular system remain under investigation in ongoing Phase 3 trials
Eder J, Prillinger K, Korn A, Geroldinger A, Trautinger F
Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020
If youre using more than one patch, want to share with a family member, or just want to stock up, a Maintenance Pack can be a fantastic way to save
Type 2 diabetes is a complex disease and the significant glucose control and weight loss achieved with once-weekly semaglutide compared with dulaglutide are encouraging, as more treatment options are needed. Safety Safety profiles were similar between patients given semaglutide and dulaglutide, and less than 10% of patients had to discontinue therapy prematurely due to adverse events across all treatment groups